-transparent.png){kind=logo}
A dose-response study was carried out in male F344 rats with a specific urinary bladder carcinogen, N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN), which was administered as a solution in drinking water for up to 112 weeks. BBN was given in four different concentrations, 50, 10, 5, and 1 ppm, to groups of 30 rats. The highest dose induced urinary bladder cancer in all rats treated by week 91, decreasing yields being associated with lower dose levels: an incidence of 76.7% was observed with 10 ppm, followed by 20.0% with 5 ppm. The lowest dose (1 ppm) only induced two cases of papilloma (6.9%).
Related Publications
N Ito, and
T Shirai, and
S Fukushima, and
M Hirose
August 1987,
Journal of the National Cancer Institute,
N Ito, and
T Shirai, and
S Fukushima, and
M Hirose
April 1988,
Japanese journal of cancer research : Gann,
N Ito, and
T Shirai, and
S Fukushima, and
M Hirose
February 1977,
Gan,
N Ito, and
T Shirai, and
S Fukushima, and
M Hirose
January 2024,
Methods in molecular biology (Clifton, N.J.),
N Ito, and
T Shirai, and
S Fukushima, and
M Hirose
December 1987,
Cancer research,
N Ito, and
T Shirai, and
S Fukushima, and
M Hirose
December 1978,
Gan,
N Ito, and
T Shirai, and
S Fukushima, and
M Hirose
February 1990,
Cancer letters,
N Ito, and
T Shirai, and
S Fukushima, and
M Hirose
August 1969,
Gan,
N Ito, and
T Shirai, and
S Fukushima, and
M Hirose
June 1983,
Gan,
N Ito, and
T Shirai, and
S Fukushima, and
M Hirose
March 1982,
Acta pathologica japonica,
